Catalent, Inc. Common Stock (NY:CTLT)

63.48 UNCHANGED

Last Price Updated: 7:00 PM EST, Dec 17, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Catalent, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

15 16 Next >

ORCL Stock Alert: Can AI Hype Really Boost Oracle 20%? ↗

August 29, 2023

Oracle (ORCL) stock is in the news Tuesday as UBS analyst Karl Keirstead makes a bull case for the information technology company's shares.

Via InvestorPlace

Topics Artificial Intelligence

China's Response To Shield Economy From Real Estate Storm, Biden Targets Cancer, Diabetes Drugs In Controversial Medicare Price Battle, Google Collaborates With Nvidia In AI Expansion: Today's Top Stories ↗

August 29, 2023

Bloomberg China Takes Drastic Measures To Shield Economy From Real Estate Storm

Via Benzinga

Topics Artificial Intelligence Economy

Catalent (CTLT) Stock Gains on Elliott Deal ↗

August 29, 2023

Catalent (CTLT) stock is getting a boost on Tuesday after the company reached an agreement with Elliott Investment Management.

Via InvestorPlace

Beaten Down COVID-19 Vaccine Partner Stock Catalent Finalizes Deal With Activist Investor, Reports Mixed Q4 Earnings ↗

August 29, 2023

Catalent Inc (NYSE: CTLT), valued at around $8 billion, has finalized a deal with activist investor Elliott Investment Management.

Via Benzinga

Catalent Earnings Preview ↗

August 28, 2023

Via Benzinga

What 19 Analyst Ratings Have To Say About Catalent ↗

August 15, 2023

Via Benzinga

Analyst Ratings for Catalent ↗

June 30, 2023

Via Benzinga

Catalent Announces Governance Enhancements and New Initiatives to Drive Value

August 29, 2023

From Catalent, Inc.

Via Business Wire

Catalent, Inc. Reports Preliminary Fourth Quarter and Fiscal 2023 Results

August 29, 2023

From Catalent, Inc.

Via Business Wire

Wegovy's Massive Demand: Novo Nordisk CEO Expresses Full Confidence In Catalent Amid Manufacturing Hurdles ↗

August 25, 2023

Novo Nordisk A/S's (NYSE: NVO) CEO, Lars Fruergaard Jorgensen, expressed confidence in Catalent Inc's (NYSE: CTLT) capability to rectify its manufacturing issues related to its

Via Benzinga

Why Novo Nordisk Stock Was Racing Higher on Wednesday ↗

August 23, 2023

When you have a hot item on the market, it's wise to ramp up production.

Via The Motley Fool

One Is Not Enough For Famed Weight Loss Drug: Novo Nordisk Taps Thermo Fisher To Ramp Up Wegovy Production ↗

August 23, 2023

Novo Nordisk A/S (NYSE: NVO) has reportedly enlisted the services of Thermo Fisher Scientific Inc (NYSE: TMO) as its second contract manufacturer for its highly sought-after

Via Benzinga

Catalent, Inc. Announces Fourth Quarter Fiscal Year 2023 Earnings Conference Webcast

August 22, 2023

From Catalent, Inc.

Via Business Wire

CATALENT ALERT: Bragar Eagel & Squire, P.C. is Investigating Catalent, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

August 21, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

Why Is Regeneron Pharmaceuticals Moving Higher Today? ↗

August 03, 2023

Regeneron Pharmaceuticals Inc (NASDAQ: REGN) earned second-quarter adjusted EPS of $10.24, up 5% Y/Y, beating the $9.92 Stre

Via Benzinga

Rising Dividend Make Zoetis a Doggone Winner

August 03, 2023

Investors that typically focus on other large cap pharmaceutical plays may wish to consider an alternative bet on pets with shares of Zoetis.

Via MarketBeat

Catalent Appoints Lisa Evoli Senior Vice President and Chief Human Resources Officer

August 01, 2023

From Catalent, Inc.

Via Business Wire

Novo Nordisk's Wegovy Supply Delays: FDA Uncovers Catalent Factory Lapses Violating Safety Regulations ↗

July 27, 2023

The production facility that fills the self-injection pens for the rapidly-growing weight-loss medication Wegovy from Novo Nordisk A/S (NYSE: NVO) has been found to have persistently violated U.S.

Via Benzinga

Tesla Recalls Over 17K EVs Over Camera & Seat Belt Issues, University Research Uncovers Unexpected Fluctuations In ChatGPT Capabilities, Juul Seeks FDA Nod For Next-Generation Vaporizer: Today's Top Stories ↗

July 20, 2023

Benzinga Tesla Recalls More Than 17,000 EVs Over Camera, Seat Belt Issues

Via Benzinga

NVDA Stock Alert; Wolfe Research Just Gave Nvidia a Big Vote of Confidence ↗

July 20, 2023

Nvidia (NVDA) stock is in the news Thursday after the tech company's shares got new coverage from Wolfe Research analysts.

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For July 20, 2023 ↗

July 20, 2023

Via Benzinga

CTLT Stock Alert: What to Know as Elliott Takes a Stake in Catalent ↗

July 20, 2023

Catalent (CTLT) stock is on the move Thursday as investors react to activist investor Elliott Investment taking a stake in the company.

Via InvestorPlace

Proxy Truces On The Rise At Catalent: Elliott Builds Significant Stake, Calls For Board Shake-Up ↗

July 20, 2023

Elliott Investment Management, an activist shareholder, has reportedly acquired a substantial stake in Catalent Inc (NYSE: CTLT). They are now advocating for a significant overhaul of the contract...

Via Benzinga

INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Investigates Catalent, Inc.’s Directors and Officers for Breach of Fiduciary Duties – CTLT

July 10, 2023

From Scott+Scott Attorneys at Law LLP

Via Business Wire

Why Catalent Stock Flopped Today ↗

June 28, 2023

The company takes the fall for a failed drug application.

Via The Motley Fool

CATALENT ALERT: Bragar Eagel & Squire, P.C. is Investigating Catalent, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

June 21, 2023

From Bragar Eagel & Squire, P.C.

Via Business Wire

Catalent Appoints Matti Masanovich Senior Vice President & Chief Financial Officer

June 20, 2023

From Catalent, Inc.

Via Business Wire

Top 5 Performing S&P 500 Stocks This Week: 2 Are AI Latecomers, 1 Was Nearly Sunk By Covid ↗

June 16, 2023

Via Benzinga

Advanced Micro Devices To Rally Around 17%? Here Are 10 Other Analyst Forecasts For Wednesday ↗

June 14, 2023

Raymond James cut the price target for W. P. Carey Inc. (NYSE: WPC) from $85 to $78. Raymond James analyst RJ Milligan maintained an Outperform rating. W. P. Carey shares fell 0.3% to $70.11 in...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 14, 2023 ↗

June 14, 2023

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

15 16 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.